The company expects revenues to between $33 million and $35 million, up from $12.1 million in the first quarter of 2014.
Historically, the company has produced approximately 14 percent of its annual revenue in the first quarter of the year.
More articles on transactions and valuation issues:
NAPA announces partnership with Virginia Eye Institute
Sentara Northern Virginia Medical Center to build $40M ASC
AmSurg stock rated at ‘buy’
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
